What is the next big drug launch in Pharma?

[Anonymous]

Is there anything in the pipeline in Pharma? What is the next big launch?

 

[Anonymous]

There aint Shit!

 

[Anonymous]

There aint Shit!

Who is in charge of the critical path work that needs to get done for the new drugs to get approved? Will the management just give up and use the lack of prospects for any new drug to trim R&D staff?

 

[Anonymous]

(a) Lotemax GEL
(b) Prolensa
(c) Expanded Indication/Label for Besivance (Pseudomonas)

 

[Anonymous]

Is there anything in the pipeline in Pharma? What is the next big launch?

If your into investing check out Lpath Inc. (LPTN).

SAN DIEGO, CA--(Marketwire -08/27/12)- Lpath, Inc. (LPTN), the industry leader in bioactive lipid-targeted therapeutics, reported that the FDA has lifted the clinical hold on iSONEP™, Lpath's anti-S1P monoclonal antibody that is being developed as a potential treatment for wet AMD and possibly other ocular disorders.

The hold was placed on iSONEP in late January 2012 after the FDA deemed that the company's fill/finish contractor was not in compliance with the FDA's Good Manufacturing Practice (cGMP) requirements for approximately a three-year period (2008-2010) -- and it was during this period that the previous iSONEP clinical vials were filled.

iSONEP was well tolerated by all patients in the Phase 1 trial, as well as by all patients treated in the PEDigree and Nexus studies before dosing was suspended in January. The company has not received any claims raising safety concerns with iSONEP.

This company is now in clinical trials with iSONEP and the results so far are extremely encouraging. Stock is currently below $1.00 but could escalate to above $8.00 if trials prove out. No sales force as yet, but will have one eventually unless they licence the drug to another company.